Tetraphase Pharmaceuticals ^{Priced, Nasdaq: TTPH}

Developing antibiotics to treat serious abdominal and urinary tract infections.

Industry: Health Care

First Day Return: 0.0%

TTPH

Developing antibiotics to treat serious abdominal and urinary tract infections.

IPO News for Tetraphase Pharmaceuticals

US IPO Weekly Recap: Seven deals price, six new filers 03/25/13
Tetraphase Pharmaceutical prices IPO below the range at $7, raising $75 million 03/20/13
Tetraphase Pharmaceuticals increases shares, decreases range for $75 million IPO 03/19/13

IPO Data
IPO Date	03/19/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$75
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Watertown, MA, United States
Founded	2006
Employees at IPO	33
Website www.tphase.com

IPO News for Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals (TTPH) Performance